期刊文献+

5-氮杂脱氧胞苷酸诱导ER阴性细胞ERα,ERβ恢复表达的实验研究

Investigation of 5-Aza-2'-deoxycytidine inducing ERα,ERβ expresssion
下载PDF
导出
摘要 目的:观察5-氮杂脱氧胞苷酸(5-Aza-dC)对ERα、ERβ阴性细胞株MDA-MB-435的ERα、ERβ的恢复表达作用。方法:采用不同终浓度(1、2.5、5、10、20μmol/L)5-Aza-dC处理ERα、ERβ阴性细胞株MDA-MB-435 96h,通过逆转录PCR(Reverse transcript PCR,RT-PCR)方法检测5'-Aza-dC处理后ER阴性MDA-MB-435乳腺癌细胞株DNMT1、ERα、ERβmRNA变化情况。结果:不同浓度5-Aza-dC均可明显抑制DNMT1 mRNA表达,20μmol/L的5-Aza-dC对DNMT1 mRNA抑制作用最为明显;采用不同浓度5-Aza-dC处理MDA-MB-435细胞96h后,ERα、ERβmRNA表达水平随5-Aza-dC浓度增大而增加,差别具有显著性(P<0.05)。结论:DNMT抑制剂5-Aza-dC可以浓度依赖性地恢复ER阴性细胞中ERα,ERβmRNA表达,说明ERα,ERβ基因启动子甲基化是引起ERα、ERβ蛋白失表达的重要机制之一。 Objective:To investigate the effect of 5-Aza-2'-deoxycytidine inducing ERα,ERβ re-expression in ERα,ERβ negative MDA-MB-435 breast cancer cell line.Methods:The level of DNMT1,ERα and ERβ mRNA in ERα,ERβ negative MDA-MB-435 breast cancer cell line before or after treated with 5-Aza-dC were tested by RT-PCR.Results: Compared with vehical group,cells treated with different concentration of 5-Aza-dC(1,2.5,5,10,20μmol/L) DNMT1 mRNA expression decreased.After been exposed to 2.5,5,10,20μmol/L 5-Aza-dC respectively ERα,ERβ mRNA expression were resorted in a dose dependent manner,there was statistically diffrence(P〈0.05).Conclusion: The expression of ERα,ERβ mRNA in ERα,ERβ negative breast cancer cell line coud be resorted by 5-Aza-dC in a dose dependent manner.So,aberrant methylation was one of the main mechanisms of inducing the loss of ERα,ERβ expression.
出处 《现代肿瘤医学》 CAS 2011年第5期842-845,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:30973559) 国家重大新药创制平台资助项目(编号:2009ZX09301-012) 辽宁省科技厅科学技术计划资助项目(编号2010225001) 辽宁省博士科研启动基金资助项目(编号:20101141)
关键词 5-氮杂脱氧胞苷酸 乳腺癌 雌激素受体 甲基化 5-Aza-2'-deoxycytidine breast cancer estrogen receptor methylation
  • 相关文献

参考文献13

  • 1Jensen EV,Jacobson HI,Walf AA,et al.Estrogen action:a historic perspective on the implications of considering alternative approaches[J].Physiol Behav,2010,99(2):151-162.
  • 2Allred DC.Issues and updates:evaluating estrogen receptor-alpha,progesterone receptor,and HER2 in breast cancer[J].Mod Pathol,2010,23 (2):52-59.
  • 3Giacinti L,Claudio PP,Lopez M,et al.Epigenetic information and estrogen receptor alpha expression in breast cancer[J].Oncologist,2006,11(1):1-8.
  • 4Li L-C,Yeh C-C,Nojima D,et al.Cloning and characterisation of human estrogen receptor β promoter[J].Biochem Biophys Res Commun,2000,275(2):682-689.
  • 5ZHANG Xu-yin,DIN Gjing-xin,YI Xiao-fang,et al.Methylation status of ERβ gene in epithelial ovary cancer[J].Fudan Univ J Med Sci,2007,34(4):532-536.
  • 6Masahiro S,Yuichiro T,Geetha P,et al.Methylation and inactivation of estrogen,progesterone,and androgen receptors in prostate cancer[J].J Nat Cancer Institute,2002,94(5):384-390.
  • 7Zhao L,Wang L,Jin F,et al.Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer[J].Breast Cancer Res Treat,2009,117(2):253-259.
  • 8Widschwendter M,Siegmund KD,Muller HM,et al.Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen[J].Cancer Res,2004,64(11):3807-3813.
  • 9Bheemanaik S,Reddy YV,Rao DN.Structure,function and mechanism of exocyclic DNA methyltransferases[J].Biochem J,2006,399(2):177-190.
  • 10Gowher H,Jeltsch A.Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy[J].Cancer Biol Ther,2004,3(11):1062-1068.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部